Ketone ester effects on metabolism and transcription

Journal of Lipid Research

Volumn 55, Issue 10, 2014, Pages 2004-2006

  Veech, Richard L ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Alzheimer's disease; Antioxidants; D beta hydroxybutyrate R 1,3 butanediol monoester; Deacetylase; Diabetes; Elevated blood ketones; Fatty acid; Ketosis

Indexed keywords

3 HYDROXYBUTYRIC ACID; ADENOSINE TRIPHOSPHATE; CARBOHYDRATE RESPONSIVE ELEMENT BINDING PROTEIN; KETONE DERIVATIVE; KETONE ESTER; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ESTER; FATTY ACID; KETONE; NICOTINAMIDE ADENINE DINUCLEOTIDE; UBIQUINONE;

CHOLESTEROL SYNTHESIS; DEACETYLATION; ENZYME ACTIVITY; FATTY ACID SYNTHESIS; GENETIC TRANSCRIPTION; GLUCOSE BLOOD LEVEL; HISTONE MODIFICATION; HUMAN; INSULIN SENSITIVITY; KETOACIDOSIS; LIPID ANALYSIS; LIPID HYDROLYSIS; METABOLIC REGULATION; METABOLISM; NONHUMAN; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; TRANSCRIPTION REGULATION; ADVERSE EFFECTS; KETOGENIC DIET; PATHOLOGY; STARVATION;

ADENOSINE TRIPHOSPHATE; ESTERS; FATTY ACIDS; HUMANS; KETOGENIC DIET; KETONES; KETOSIS; NAD; STARVATION; UBIQUINONE;

EID: 84904384275     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R046292     Document Type: Review

References (28)

1. Krebs, H. A. 1966. The regulation of the release of ketone bodies by the liver. Adv. Enzyme Regul. 4: 339-354.
2. Cahill, G. F., Jr., and R. L. Veech. 2003. Ketoacids? Good medicine? Trans. Am. Clin. Climatol. Assoc. 114: 149-161; discussion 162-163.
3. Cahill, G. F., Jr. 1970. Starvation in man. N. Engl. J. Med. 282: 668-675.
4. Cahill, G. F., Jr. 2006. Fuel metabolism in starvation. Annu. Rev. Nutr. 26: 1-22.
5. Reichard, G. A., O. E. Owen, A. C. Haff, P. Paul, and W. M. Bortz. 1974. Ketone-body production and oxidation in fasting obese humans. J. Clin. Invest. 53: 508-515.
6. Sampath, A., E. H. Kossoff, S. L. Furth, P. L. Pyzik, and E. P. Vining. 2007. Kidney stones and the ketogenic diet: risk factors and prevention. J. Child Neurol. 22: 375-378.
7. Murín, R., and B. Hamprecht. 2008. Metabolic and regulatory roles of leucine in neural cells. Neurochem. Res. 33: 279-284.
8. Kersten, S., B. Desvergne, and W. Wahli. 2000. Roles of PPARs in health and disease. Nature. 405: 421-424.
9. Kwiterovich, P. O., Jr., E. P. Vining, P. Pyzik, R. Skolasky, Jr., and J. M. Freeman. 2003. Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. JAMA. 290: 912-920.
10. Kashiwaya, Y., T. Takeshima, N. Mori, K. Nakashima, K. Clarke, and R. L. Veech. 2000. D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc. Natl. Acad. Sci. USA. 97: 5440-5444.
11. Sato, K., Y. Kashiwaya, C. A. Keon, N. Tsuchiya, M. T. King, G. K. Radda, B. Chance, K. Clarke, and R. L. Veech. 1995. Insulin, ketone bodies, and mitochondrial energy transduction. FASEB J. 9: 651-658.
12. Li, L., and J. L. Messina. 2009. Acute insulin resistance following injury. Trends Endocrinol. Metab. 20: 429-435.
13. Kashiwaya, Y., M. T. King, and R. L. Veech. 1997. Substrate signaling by insulin: a ketone bodies ratio mimics insulin action in heart. Am. J. Cardiol. 80: 50A-64A.
14. Shimazu, T., M. D. Hirschey, J. Newman, W. He, K. Shirakawa, N. Le Moan, C. A. Grueter, H. Lim, L. R. Saunders, R. D. Stevens, et al. 2013. Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science. 339: 211-214.
15. Clarke, K., K. Tchabanenko, R. Pawlosky, E. Carter, M. Todd King, K. Musa-Velosa, M. Ho, A. Roberts, J. Robertson, T. B. Vanitallie, et al. 2012. Kinetics, safety and tolerability of (R)-3-hyroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects. Regul. Toxicol. Pharmacol. 63: 401-408.
16. Veech, R. L. 2004. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot. Essent. Fatty Acids. 70: 309-319.
17. Veech, R. L., and M. A. Mehlman. 1972. Liver metabolite content, redox and phosphorylation states in rats fed diets containing 1,3-butandiol and ethanol. In Energy Metabolism and the Regulation of Metabolic Processes in Mitochondria. M. A. Mehlman and R. W. Hanson, editors. Academic Press, New York. 171-183.
18. Vannucci, S. J., and I. A. Simpson. 2003. Developmental switch in brain nutrient transporter expression in the rat. Am. J. Physiol. Endocrinol. Metab. 285: E1127-E1134.
19. Clarke, K., K. Tchabanenko, R. Pawlosky, E. Carter, N. S. Knight, A. J. Murray, L. E. Cochlin, M. T. King, A. W. Wong, A. Roberts, et al. 2012. Oral 28-day and developmental toxicity studies of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate. Regul. Toxicol. Pharmacol. 63: 196-208.
20. Kashiwaya, Y., R. Pawlosky, W. Markis, M. T. King, C. Bergman, S. Srivastava, A. Murray, K. Clarke, and R. L. Veech. 2010. A ketone ester diet increased brain malonyl CoA and uncoupling protein 4 and 5 while decreasing food intake in the normal Wistar rat. J. Biol. Chem. 285: 25950-25956.
21. Mukherjee, C., and R. L. Jungas. 1975. Activation of pyruvate dehydrogenase in adipose tissue by insulin. Evidence for an effect of insulin on pyruvate dehydrogenase phosphate phosphatase. Biochem. J. 148: 229-235.
22. Denton, R. M., P. J. Randle, B. J. Bridges, R. H. Cooper, A. L. Kerbey, H. T. Pask, D. L. Severson, D. Stansbie, and S. Whitehouse. 1975. Regulation of mammalian pyruvate dehydrogenase. Mol. Cell. Biochem. 9: 27-53.
23. Shimomura, I., Y. Bashmakov, S. Ikemoto, J. D. Horton, M. S. Brown, and J. L. Goldstein. 1999. Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. USA. 96: 13656-13661.
24. Goldstein, J. L., R. A. DeBose-Boyd, and M. S. Brown. 2006. Protein sensors for membrane sterols. Cell. 124: 35-46.
25. Nakagawa, T., Q. Ge, R. Pawlosky, R. M. Wynn, R. L. Veech, and K. Uyeda. 2013. Metabolite regulation of nucleo-cytosolic trafficking of carbohydrate response element-binding protein (ChREBP): role of ketone bodies. J. Biol. Chem. 288: 28358-28367.
26. Seyfried, T. N., T. M. Sanderson, M. M. El Abbadi, R. McGowan, and P. Mukherjee. 2003. Role of glucose and ketone bodies in the metabolic control of experimental brain cancer. Br. J. Cancer. 89: 1375-1382.
27. Long, P. M., S. W. Tighe, H. E. Driscoll, J. R. Moffett, A. M. Namboodiri, M. S. Viapiano, S. E. Lawler, and D. M. Jaworski. 2013. Acetate supplementation induces growth arrest of NG2/PDGFRα-positive oligodendroglioma-derived tumor-initiating cells. PLoS ONE. 8: e80714.
28. Joshi, P., O. I. Quach, S. Giguere, and I. Cristea. 2013. A functional proteomics perspective of DBC1 as a regulator of transcription. J. Proteomics Bioinform. Suppl 2: 002.